Niagen Bioscience (NAGE) vs Nature's Sunshine Products (NATR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nature's Sunshine Products (NATR) has outperformed Niagen Bioscience (NAGE) over the past year, losing 16.2% versus a loss of 64.2%. Over five years, NATR leads with a -18.2% price change compared with -58.2% for NAGE. Nature's Sunshine Products is the larger company by market cap ($223.2 million vs $212.5 million), about 1.1 times the size.
On valuation, Nature's Sunshine Products trades at a lower forward P/E (10.3x vs 26.8x for Niagen Bioscience).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAGE | NATR |
|---|---|---|
| Share price | $2.69 | $12.69 |
| Market cap | $212.45M | $223.20M |
| 1-day change | +0.94% | +0.91% |
| YTD return | -58.18% | -41.75% |
| 1-year return | -64.20% | -16.20% |
| 5-year return | -58.18% | -18.22% |
| P/E ratio (TTM) | 14.13 | 12.56 |
| Forward P/E | 26.85 | 10.31 |
| EPS (TTM) | $0.19 | $1.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $28.14 |
| 52-week low | $2.61 | $12.31 |
| Distance from 52-week high | -66.23% | -54.92% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +349.91% | +140.44% |
| Average volume | 585.61K | 160.23K |
| Shares outstanding | 79.13M | 17.60M |
| Employees | 117 | 806 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NATR has outperformed NAGE by 48.0 percentage points over the past year.
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
About Nature's Sunshine Products
NATR stock →Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees
NAGE vs NATR FAQ
Which is bigger, Niagen Bioscience or Nature's Sunshine Products?
Nature's Sunshine Products (NATR) is larger, with a market capitalization of $223.20M compared with $212.45M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, NAGE or NATR?
NATR returned -16.20% over the past 12 months, compared with -64.20% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, NAGE or NATR?
NATR has the lower trailing P/E at 12.6, versus 14.1 for NAGE. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Niagen Bioscience and Nature's Sunshine Products in the same industry?
Both are in the Health Care sector, but in different industries: Medicinal Chemicals and Botanical Products for Niagen Bioscience and Biotechnology: Pharmaceutical Preparations for Nature's Sunshine Products.